Cytomegalovirus Diagnostic Market: By Sample Extract, By Drug Type, By Test Type, and Hybrid Capture Assay), By Application Type, By End User, and Region Forecast 2019-2030

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Cytomegalovirus (CMV) Diagnostic Market Size, Share, Growth, Trends, and Global Industry Analysis: By Sample Extract (Urine, and Blood), By Drug Type (Valganciclovir, Ganciclovir, Cidofovir, Foscarnet, and Others), By Test Type (Serology, Cell Culture, Antigenemia, Polymerase Chain Reaction Amplification, Immunohistochemistry, Nucleic Acid Sequence Based Amplification (NASBA), and Hybrid Capture Assay), By Application Type (Retinitis, Pneumonia, Gastrointestinal Ulcers, Encephalitis, and Others (Mouth Ulcers, Pharyngitis, etc.), By End User (Hospitals, Diagnostic Centers, Clinics, and Others), and Region Forecast 2019-2030

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Cytomegalovirus Diagnostics Market size was valued at US$ 73.6 million in 2023 and is poised to grow at a significant CAGR of 6.1% from 2024-2030. The global cytomegalovirus (CMV) diagnostic market held a significant market share during the estimated period. CMV is a common virus that causes serious complications, especially in individuals having weak immune systems who have AIDS/HIV, newborns, and organ transplant recipients. The main drivers for the market growth are huge investments in research and development by the players, the introduction of novel medicines, and the rise in cases of cytomegalovirus infections.

According to the National Library of Medicine report of August 2023, 60% to 70% of adults get infected by CMV in developed countries and almost 100% in developing countries which is the driving dynamic for the CMV diagnostic market. The market for CMV treatments is vulnerable to falling transplant rates and decreasing CMV prevalence carried on by highly active antiretroviral therapy (HAART). However, alternatives such as Cryotherapy and laser therapy compete for market share.

Key Developments

  • In September 2022, ProBioGen agreed with the City of Hope to manufacture the CMV vaccine for clinical trials and commercial distribution which helped the company accelerate the development and production of the CMV vaccine which could save many lives.
  • In November 2021, the US Food and Drug Administration (FDA) approved maribavir, the Takeda pharmaceuticals product that can treat pediatric patients of 12 years of age, adults, and also the elderly with post-transplant. Cytomegalovirus infection is refractory to treatment with ganciclovir, cidofovir, valganciclovir, or foscarnet. The FDA’s approval has strengthened the overall company’s market position. 

summary download arrow Download Free Sample

Global Cytomegalovirus Diagnostics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

6.1%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Cytomegalovirus Diagnostics Market Dynamics

The prevalence of viral infections among AIDS patients increases due to the weak immune system which helps in the cytomegalovirus (CMV) diagnostic market growth during the forecast period. According to the CDC, around 36.7 million populations were suffering from HIV infection in 2017 and the widespread availability of antiviral medications is anticipated to stimulate the demand for effective treatment options. Moreover, the lifestyle of people and the increasing number of initiatives by the government to spread awareness will drive the growth of the cytomegalovirus diagnostic market. 

Global Cytomegalovirus Diagnostics Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 73.6 million

Market CAGR

6.1%

By Sample Extract

  • Urine
  • Blood

By Drug Type

  • Valganciclovir
  • Ganciclovir
  • Cidofovir
  • Foscarnet
  • Others

By Test Type

  • Serology
  • Cell culture
  • Antigenemia
  • Polymerase Chain Reaction Amplification
  • Immunohistochemistry
  • Nucleic Acid sequence based Amplification (NASBA)
  • Hybrid capture assay

By Application

  • Retinitis
  • Pneumonia
  • Gastrointestinal ulcers
  • Encephalitis
  • Stem cell transplantation
  • Organ transplantation
  • Others (Mouth Ulcers, Pharyngitis, etc.)

By End User

  • Hospitals
  • Diagnostic Centres
  • Clinics
  • Others

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The cytomegalovirus diagnostics market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

Cytomegalovirus Diagnostics Market size was valued at US$ 73.6 million in 2023 and is poised to grow at a CAGR of 6.1% during the forecast period 2023-29.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

The leading players operating in the cytomegalovirus market are: Pfizer Inc. (U.S.) GlaxoSmithKline plc (U.K.) Novartis AG (Switzerland) Mylan N.V. (U.S.) Teva Pharmaceutical Industries Ltd.(Israel) Sanofi (France) F. Hoffmann-La Roche Ltd. (Switzerland) Zydus Cadila (India) Lupin (India) Cipla Inc. (U.S.) Aurobindo Pharma (India) Glenmark Pharmaceuticals Limited (India) Endo International plc (Ireland) AstraZeneca (U.K.) Johnson & Johnson Private Limited (U.S.) Bio-Rad Laboratories, Inc. (U.S.) BD (U.S.) Abbott (US) Astellas Pharma Inc. (Japan) Merck & Co., Inc. (U.S.).

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Cytomegalovirus (CMV) Diagnostic Market Introduction 
2.1.Global Cytomegalovirus (CMV) Diagnostic Market  - Taxonomy
2.2.Global Cytomegalovirus (CMV) Diagnostic Market  - Definitions
2.2.1.By Sample Extract
2.2.2.By Drug Type
2.2.3.By Test Type
2.2.4.By Application
2.2.5.By End User
2.2.6.Region
3.Global Cytomegalovirus (CMV) Diagnostic Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Cytomegalovirus (CMV) Diagnostic Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Cytomegalovirus (CMV) Diagnostic Market  By Sample Extract, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Urine
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Blood
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6.Global Cytomegalovirus (CMV) Diagnostic Market  By Drug Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Valganciclovir
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Ganciclovir
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Cidofovir
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Foscarnet
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Others
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7.Global Cytomegalovirus (CMV) Diagnostic Market  By Test Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Serology
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Cell culture
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Antigenemia
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Polymerase Chain Reaction Amplification
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Immunohistochemistry
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
7.6. Nucleic Acid sequence based Amplification (NASBA)
7.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.6.3. Market Opportunity Analysis 
7.7. Hybrid capture assay
7.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.7.3. Market Opportunity Analysis 
8.Global Cytomegalovirus (CMV) Diagnostic Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Retinitis
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Pneumonia
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Gastrointestinal ulcers
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Encephalitis
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Stem cell transplantation
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
8.6. Organ transplantation
8.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.6.3. Market Opportunity Analysis 
8.7. Others (Mouth Ulcers, Pharyngitis, etc.)
8.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.7.3. Market Opportunity Analysis 
9.Global Cytomegalovirus (CMV) Diagnostic Market  By End-users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Hospitals
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Diagnostic Centres
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Clinics
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Others
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
10.Global Cytomegalovirus (CMV) Diagnostic Market  By Region, 20110 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. North America
10.1.1. Market Analysis, 20110 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
10.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
10.1.3. Market Opportunity Analysis 
10.2. Europe
10.2.1. Market Analysis, 20110 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
10.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
10.2.3. Market Opportunity Analysis 
10.3. Asia Pacific (APAC)
10.3.1. Market Analysis, 20110 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
10.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
10.3.3. Market Opportunity Analysis 
10.4. Middle East and Africa (MEA)
10.4.1. Market Analysis, 20110 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
10.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
10.4.3. Market Opportunity Analysis 
10.5. Latin America
10.5.1. Market Analysis, 20110 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
10.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
10.5.3. Market Opportunity Analysis 
11.North America Cytomegalovirus (CMV) Diagnostic Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Sample Extract Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Urine
11.1.2.Blood
11.2.  Drug Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Valganciclovir
11.2.2.Ganciclovir
11.2.3.Cidofovir
11.2.4.Foscarnet
11.2.5.Others
11.3.  Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Serology
11.3.2.Cell culture
11.3.3.Antigenemia
11.3.4.Polymerase Chain Reaction Amplification
11.3.5.Immunohistochemistry
11.3.6.Nucleic Acid sequence based Amplification (NASBA)
11.3.7.Hybrid capture assay
11.4.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Retinitis
11.4.2.Pneumonia
11.4.3.Gastrointestinal ulcers
11.4.4.Encephalitis
11.4.5.Stem cell transplantation
11.4.6.Organ transplantation
11.4.7.Others (Mouth Ulcers, Pharyngitis, etc.)
11.5.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Hospitals
11.5.2.Diagnostic Centres
11.5.3.Clinics
11.5.4.Others
11.6.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.6.1.United States of America (USA)
11.6.2.Canada
12.Europe Cytomegalovirus (CMV) Diagnostic Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Sample Extract Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Urine
12.1.2.Blood
12.2.  Drug Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Valganciclovir
12.2.2.Ganciclovir
12.2.3.Cidofovir
12.2.4.Foscarnet
12.2.5.Others
12.3.  Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Serology
12.3.2.Cell culture
12.3.3.Antigenemia
12.3.4.Polymerase Chain Reaction Amplification
12.3.5.Immunohistochemistry
12.3.6.Nucleic Acid sequence based Amplification (NASBA)
12.3.7.Hybrid capture assay
12.4.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Retinitis
12.4.2.Pneumonia
12.4.3.Gastrointestinal ulcers
12.4.4.Encephalitis
12.4.5.Stem cell transplantation
12.4.6.Organ transplantation
12.4.7.Others (Mouth Ulcers, Pharyngitis, etc.)
12.5.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.Hospitals
12.5.2.Diagnostic Centres
12.5.3.Clinics
12.5.4.Others
12.6.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.6.1.Germany
12.6.2.France
12.6.3.Italy
12.6.4.United Kingdom (UK)
12.6.5.Spain
13.Asia Pacific (APAC) Cytomegalovirus (CMV) Diagnostic Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Sample Extract Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Urine
13.1.2.Blood
13.2.  Drug Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Valganciclovir
13.2.2.Ganciclovir
13.2.3.Cidofovir
13.2.4.Foscarnet
13.2.5.Others
13.3.  Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Serology
13.3.2.Cell culture
13.3.3.Antigenemia
13.3.4.Polymerase Chain Reaction Amplification
13.3.5.Immunohistochemistry
13.3.6.Nucleic Acid sequence based Amplification (NASBA)
13.3.7.Hybrid capture assay
13.4.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Retinitis
13.4.2.Pneumonia
13.4.3.Gastrointestinal ulcers
13.4.4.Encephalitis
13.4.5.Stem cell transplantation
13.4.6.Organ transplantation
13.4.7.Others (Mouth Ulcers, Pharyngitis, etc.)
13.5.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.Hospitals
13.5.2.Diagnostic Centres
13.5.3.Clinics
13.5.4.Others
13.6.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.6.1.China
13.6.2.India
13.6.3.Australia and New Zealand (ANZ)
13.6.4.Japan
13.6.5.Rest of APAC
14.Middle East and Africa (MEA) Cytomegalovirus (CMV) Diagnostic Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14.1. Sample Extract Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Urine
14.1.2.Blood
14.2.  Drug Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Valganciclovir
14.2.2.Ganciclovir
14.2.3.Cidofovir
14.2.4.Foscarnet
14.2.5.Others
14.3.  Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Serology
14.3.2.Cell culture
14.3.3.Antigenemia
14.3.4.Polymerase Chain Reaction Amplification
14.3.5.Immunohistochemistry
14.3.6.Nucleic Acid sequence based Amplification (NASBA)
14.3.7.Hybrid capture assay
14.4.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Retinitis
14.4.2.Pneumonia
14.4.3.Gastrointestinal ulcers
14.4.4.Encephalitis
14.4.5.Stem cell transplantation
14.4.6.Organ transplantation
14.4.7.Others (Mouth Ulcers, Pharyngitis, etc.)
14.5.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Hospitals
14.5.2.Diagnostic Centres
14.5.3.Clinics
14.5.4.Others
14.6.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.6.1.GCC Countries
14.6.2.South Africa
14.6.3.Rest of MEA
15.Latin America Cytomegalovirus (CMV) Diagnostic Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
15.1. Sample Extract Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
15.1.1.Urine
15.1.2.Blood
15.2.  Drug Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
15.2.1.Valganciclovir
15.2.2.Ganciclovir
15.2.3.Cidofovir
15.2.4.Foscarnet
15.2.5.Others
15.3.  Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
15.3.1.Serology
15.3.2.Cell culture
15.3.3.Antigenemia
15.3.4.Polymerase Chain Reaction Amplification
15.3.5.Immunohistochemistry
15.3.6.Nucleic Acid sequence based Amplification (NASBA)
15.3.7.Hybrid capture assay
15.4.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
15.4.1.Retinitis
15.4.2.Pneumonia
15.4.3.Gastrointestinal ulcers
15.4.4.Encephalitis
15.4.5.Stem cell transplantation
15.4.6.Organ transplantation
15.4.7.Others (Mouth Ulcers, Pharyngitis, etc.)
15.5.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
15.5.1.Hospitals
15.5.2.Diagnostic Centres
15.5.3.Clinics
15.5.4.Others
15.6.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
15.6.1.Brazil
15.6.2.Mexico
15.6.3.Rest of LA
16. Competition Landscape
16.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
16.2.1.Roche Diagnostics International Ltd
16.2.2.Luminex Corp
16.2.3.Abbott Laboratories
16.2.4.Qiagen NV
16.2.5.Beckman Coulter Inc
16.2.6.Pfizer Inc. (U.S.)
16.2.7.GlaxoSmithKline plc (U.K.)
16.2.8.Novartis AG (Switzerland)
16.2.9.Teva Pharmaceutical Industries Ltd.(Israel)
16.2.10.Sanofi (France)
16.2.11.Hoffmann-La Roche Ltd. (Switzerland)
16.2.12.Zydus Cadila (India)
17. Research Methodology 
18. Appendix and Abbreviations 

Key Market Players

  • Roche Diagnostics International Ltd
  • Luminex Corp
  • Abbott Laboratories
  • Qiagen NV
  • Beckman Coulter Inc
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • Hoffmann-La Roche Ltd.
  • Zydus Cadila
  • Cipla Inc.
  • Aurobindo Pharma
  • Endo International plc
  • AstraZeneca
  • Johnson & Johnson Private Limited
  • Bio-Rad Laboratories, Inc.
  • Abbott
  • Merck & Co., Inc.

Related Industry Reports

Cytomegalovirus Testing Market

Pneumonia Therapeutics Market

Blood And Urine Collection Market

Urine Analyzers Market